4 171

Cited 29 times in

Epidermolysis bullosa acquisita

Authors
 J.H. Kim  ;  S.-C. Kim 
Citation
 Journal of the European Academy of Dermatology and Venereology, Vol.27(10) : 1204-1213, 2013 
Journal Title
 Journal of the European Academy of Dermatology and Venereology 
ISSN
 0926-9959 
Issue Date
2013
Abstract
Epidermolysis bullosa acquisita (EBA) is a chronic autoimmune subepidermal bullous disease with clinical features similar to the genetic form of dystrophic epidermolysis bullosa. EBA is characterized by the presence of autoantibodies against type VII collagen which is a major component of the anchoring fibrils at the dermal-epidermal junction. EBA can be divided into two main clinical types; mechanobullous and inflammatory EBA. Mechanobullous EBA, referred to as classic EBA, presents with skin fragility, blisters and dystrophic changes on trauma-prone areas. Inflammatory EBA resembles other autoimmune subepidermal bullous diseases. Compelling evidence from mouse models supports a pathogenic role of autoantibodies against type VII collagen in EBA. Treatment of EBA is often unsatisfactory. The most widely used systemic treatment is corticosteroids. Colchicine and dapsone have been reported to be good treatment modalities when combined with corticosteroids. Some intractable cases of EBA have successfully been treated with intravenous immunoglobulin or rituximab.
Full Text
http://onlinelibrary.wiley.com/doi/10.1111/jdv.12096/abstract
DOI
10.1111/jdv.12096
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Dermatology (피부과학교실) > 1. Journal Papers
Yonsei Authors
김수찬(Kim, Soo Chan) ORCID logo https://orcid.org/0000-0002-2327-4755
김종훈(Kim, Jong Hoon) ORCID logo https://orcid.org/0000-0002-3385-8180
Export
RIS (EndNote)
XLS (Excel)
XML
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/89090
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse